ICU Medical, Incorporated  

(Public, NASDAQ:ICUI)   Watch this stock  
Find more results for Dianna Finney�
87.02
+0.55 (0.64%)
After Hours: 87.04 +0.02 (0.02%)
Feb 8, 4:59PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 85.56 - 87.53
52 week 84.02 - 124.69
Open 86.20
Vol / Avg. 306,571.00/176,760.00
Mkt cap 1.35B
P/E 30.36
Div/yield     -
EPS 2.87
Shares 15.98M
Beta 0.47
Inst. own 90%
May 3, 2016
Q1 2016 ICU Medical Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 3, 2016
Q4 2015 ICU Medical Inc Earnings Call - Webcast
Feb 3, 2016
Q4 2015 ICU Medical Inc Earnings Release
Jan 13, 2016
ICU Medical Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 18.91% 8.52%
Operating margin 28.79% 12.62%
EBITD margin - 20.56%
Return on average assets 11.05% 5.06%
Return on average equity 11.81% 5.41%
Employees 2,280 -
CDP Score - -

Address

951 Calle Amanecer
SAN CLEMENTE, CA 92673
United States - Map
+1-949-3662183 (Phone)
+1-949-3668368 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ICU Medical, Inc. is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and innovative hemodynamic monitoring systems. The Company’s products are used in acute care hospitals and ambulatory clinics in more than 60 countries worldwide. Its products are categorized into three market segments: Infusion Therapy, Critical Care and Oncology. Its primary products include MicroClave and MicroClave Clear, Anti-Microbial MicroClave, Tego needlefree hemodialysis connector, Transpac disposable pressure transducers, Pulmonary artery thermodilution catheters, ChemoLock CSTD and components, and Diana hazardous drug compounding system, among others.

Officers and directors

Vivek Jain Chairman of the Board, Chief Executive Officer
Age: 42
Bio & Compensation  - Reuters
Scott E. Lamb Chief Financial Officer
Age: 52
Bio & Compensation  - Reuters
Steven C. Riggs Vice President - Operations
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alison D. Burcar Vice President, General Manager - Infusion Systems
Age: 42
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tom McCall Vice President, General Manager - Critical Care
Age: 57
Bio & Compensation  - Reuters
Elisha W. Finney Director
Age: 53
Bio & Compensation  - Reuters
Joseph R. Saucedo Independent Director
Age: 72
Bio & Compensation  - Reuters
Richard H. Sherman M.D. Independent Director
Age: 68
Bio & Compensation  - Reuters
Robert S. Swinney M.D. Independent Director
Age: 68
Bio & Compensation  - Reuters